FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2756160868> ?p ?o ?g. }

• W2756160868 endingPage "e1377874" @default.
• W2756160868 startingPage "e1377874" @default.
• W2756160868 abstract "The redirection of T cell activity using bispecific antibodies is one of the most promising cancer immunotherapy approaches currently in development, but it is limited by cytokine storm-related toxicities, as well as the pharmacokinetics and tumor-penetrating capabilities of current bispecific antibody formats. Here, we have engineered the ATTACK (Asymmetric Tandem Trimerbody for T cell Activation and Cancer Killing), a novel T cell-recruiting bispecific antibody which combines three EGFR-binding single-domain antibodies (VHH; clone EgA1) with a single CD3-binding single-chain variable fragment (scFv; clone OKT3) in an intermediate molecular weight package. The two specificities are oriented in opposite directions in order to simultaneously engage cancer cells and T cell effectors, and thereby promote immunological synapse formation. EgA1 ATTACK was expressed as a homogenous, non-aggregating, soluble protein by mammalian cells and demonstrated an enhanced binding to EGFR, but not CD3, when compared to the previously characterized tandem bispecific antibody which has one EgA1 VHH and one OKT3 scFv per molecule. EgA1 ATTACK induced synapse formation and early signaling pathways downstream of TCR engagement at lower concentrations than the tandem VHH-scFv bispecific antibody. Furthermore, it demonstrated extremely potent, dose-dependent cytotoxicity when retargeting human T cells towards EGFR-expressing cells, with an efficacy over 15-fold higher than that of the tandem VHH-scFv bispecific antibody. These results suggest that the ATTACK is an ideal format for the development of the next-generation of T cell-redirecting bispecific antibodies." @default.
• W2756160868 created "2017-09-25" @default.
• W2756160868 creator A5000135655 @default.
• W2756160868 creator A5003276179 @default.
• W2756160868 creator A5009059698 @default.
• W2756160868 creator A5013056108 @default.
• W2756160868 creator A5014831048 @default.
• W2756160868 creator A5023885000 @default.
• W2756160868 creator A5030041355 @default.
• W2756160868 creator A5036721454 @default.
• W2756160868 creator A5041117771 @default.
• W2756160868 creator A5042598309 @default.
• W2756160868 creator A5048998113 @default.
• W2756160868 creator A5054576346 @default.
• W2756160868 creator A5058966254 @default.
• W2756160868 creator A5065821225 @default.
• W2756160868 creator A5077717500 @default.
• W2756160868 creator A5078328621 @default.
• W2756160868 creator A5089896171 @default.
• W2756160868 date "2017-09-27" @default.
• W2756160868 modified "2023-10-16" @default.
• W2756160868 title "ATTACK, a novel bispecific T cell-recruiting antibody with trivalent EGFR binding and monovalent CD3 binding for cancer immunotherapy" @default.
• W2756160868 cites W1554880727 @default.
• W2756160868 cites W1943878720 @default.
• W2756160868 cites W1966422780 @default.
• W2756160868 cites W1969424287 @default.
• W2756160868 cites W1979079501 @default.
• W2756160868 cites W1984227078 @default.
• W2756160868 cites W1987240796 @default.
• W2756160868 cites W1996261598 @default.
• W2756160868 cites W1996815863 @default.
• W2756160868 cites W1998836855 @default.
• W2756160868 cites W1998932713 @default.
• W2756160868 cites W2002674291 @default.
• W2756160868 cites W2003130551 @default.
• W2756160868 cites W2011581231 @default.
• W2756160868 cites W2012203161 @default.
• W2756160868 cites W2020634797 @default.
• W2756160868 cites W2024890197 @default.
• W2756160868 cites W2027922729 @default.
• W2756160868 cites W2030205190 @default.
• W2756160868 cites W2031915840 @default.
• W2756160868 cites W2032185672 @default.
• W2756160868 cites W2039060347 @default.
• W2756160868 cites W2041402908 @default.
• W2756160868 cites W2051071528 @default.
• W2756160868 cites W2056362227 @default.
• W2756160868 cites W2058529228 @default.
• W2756160868 cites W2059739979 @default.
• W2756160868 cites W2060209794 @default.
• W2756160868 cites W2068125497 @default.
• W2756160868 cites W2073557222 @default.
• W2756160868 cites W2086146164 @default.
• W2756160868 cites W2088729407 @default.
• W2756160868 cites W2127430114 @default.
• W2756160868 cites W2136504336 @default.
• W2756160868 cites W2136656832 @default.
• W2756160868 cites W2136822754 @default.
• W2756160868 cites W2142678478 @default.
• W2756160868 cites W2145061993 @default.
• W2756160868 cites W2163889515 @default.
• W2756160868 cites W2169921558 @default.
• W2756160868 cites W2261057385 @default.
• W2756160868 cites W2314037182 @default.
• W2756160868 cites W2405839966 @default.
• W2756160868 cites W2470634803 @default.
• W2756160868 cites W2524814182 @default.
• W2756160868 cites W2571138221 @default.
• W2756160868 cites W4211232835 @default.
• W2756160868 doi "https://doi.org/10.1080/2162402x.2017.1377874" @default.
• W2756160868 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5739562" @default.
• W2756160868 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29296540" @default.
• W2756160868 hasPublicationYear "2017" @default.
• W2756160868 type Work @default.
• W2756160868 sameAs 2756160868 @default.
• W2756160868 citedByCount "53" @default.
• W2756160868 countsByYear W27561608682018 @default.
• W2756160868 countsByYear W27561608682019 @default.
• W2756160868 countsByYear W27561608682020 @default.
• W2756160868 countsByYear W27561608682021 @default.
• W2756160868 countsByYear W27561608682022 @default.
• W2756160868 countsByYear W27561608682023 @default.
• W2756160868 crossrefType "journal-article" @default.
• W2756160868 hasAuthorship W2756160868A5000135655 @default.
• W2756160868 hasAuthorship W2756160868A5003276179 @default.
• W2756160868 hasAuthorship W2756160868A5009059698 @default.
• W2756160868 hasAuthorship W2756160868A5013056108 @default.
• W2756160868 hasAuthorship W2756160868A5014831048 @default.
• W2756160868 hasAuthorship W2756160868A5023885000 @default.
• W2756160868 hasAuthorship W2756160868A5030041355 @default.
• W2756160868 hasAuthorship W2756160868A5036721454 @default.
• W2756160868 hasAuthorship W2756160868A5041117771 @default.
• W2756160868 hasAuthorship W2756160868A5042598309 @default.
• W2756160868 hasAuthorship W2756160868A5048998113 @default.
• W2756160868 hasAuthorship W2756160868A5054576346 @default.
• W2756160868 hasAuthorship W2756160868A5058966254 @default.
• W2756160868 hasAuthorship W2756160868A5065821225 @default.
• W2756160868 hasAuthorship W2756160868A5077717500 @default.

• next